title: Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.
authors.affiliation: Second Department of Medicine, Kurume University School of Medicine, Kurume, Japan. ray@med.kurume-u.ac.jp
authors.forename: Reiichiro
authors.initials: R
authors.lastname: Kuwahara
authors.forename: Ryukichi
authors.initials: R
authors.lastname: Kumashiro
authors.forename: Hiroto
authors.initials: H
authors.lastname: Inoue
authors.forename: Ryo
authors.initials: R
authors.lastname: Tanabe
authors.forename: Eisuke
authors.initials: E
authors.lastname: Tanaka
authors.forename: Teruko
authors.initials: T
authors.lastname: Hino
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Ide
authors.forename: Yuriko
authors.initials: Y
authors.lastname: Koga
authors.forename: Michio
authors.initials: M
authors.lastname: Sata
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000378:metabolism; D004351:Drug Resistance; D006509:Hepatitis B / Q000188:drug therapy* / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D017093:Liver Failure / Q000188:drug therapy* / Q000821:virology*; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates; D019233:Retreatment; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D000225:Adenine; C106812:adefovir dipivoxil